Brand entity

Boehringer Ingelheim

Boehringer Ingelheim is a German pharmaceutical group with a top-tier animal health division, familiar to cat owners through Frontline and Broadline parasite control.

Boehringer Ingelheim
Brand

Overview

Read the full profile

The family-owned German pharma company became a leading animal health player after acquiring Merial in 2017.

Frontline uses fipronil against fleas and ticks, while Broadline spot-on extends coverage to multiple internal and external parasites; the portfolio also includes NexGard Combo for cats, sold via veterinary channels in weight-based doses.

Related products